
LAIs Tied to Lower Relapse, Mortality Risk in Schizophrenia
Oct 16, 2025 · Long-acting injectable antipsychotics are linked to a lower risk for disease relapse and mortality than oral antipsychotics in adults with schizophrenia, a new study shows.
Forget the Tremor: These Symptoms Come First in Parkinson’s
Jun 10, 2025 · It often appears alongside other signs like a softer, monotone voice or reduced arm swing while walking — both early signs of extrapyramidal dysfunction.
Metoclopramide in the Treatment of Diabetic Gastroparesis
Acute Dystonic Reactions Acute dystonic reactions are the most frequent extrapyramidal side effects (EPS) from metoclopramide and typically occur within 24–48 h of initiating treatment, thus ...
Novel Drug Safe, Effective for Acute Schizophrenia - Medscape
May 23, 2025 · The novel PDE10A inhibitor CPL'36 offers a new mechanism of action and is both safe and effective for acute exacerbations of schizophrenia, new research suggests.
Untreated Tardive Dyskinesia Hinders Use of Antipsychotics
Jul 29, 2024 · Tardive dyskinesia, often underdiagnosed and undertreated, hinders patient adherence to antipsychotics, affecting mental health treatment and caregivers' well-being, reports Dr Daniel …
Treatment Considerations for Psychiatric Syndromes Associated with …
Another important consideration is HIV-infected patients' increased sensitivity to antipsychotic-induced extrapyramidal symptoms, thought to be related to the damage to basal ganglia observed in ...
Behavioural Changes in a Child Reveal Manganese Toxicity
2 days ago · A child with chronic liver disease developed abrupt behavioural and neurological symptoms that were traced to dietary manganese exposure and responded to chelation.
New Management Approaches for Gastroparesis - Page 4 - Medscape
It has the advantage of either parenteral (including subcutaneous) or oral dosing, but side effects including extrapyramidal reactions are not uncommon. [43] Tardive dyskinesia represents a ...
'Impressive' New Data on Novel Schizophrenia Hopeful KarXT
May 8, 2024 · The novel investigational antipsychotic KarXT was effective and well tolerated in adults with schizophrenia experiencing acute psychosis in a second phase 3 trial.
Depression, Extrapyramidal Symptoms, Dementia and an ... - Medscape
A patient symptoms of functional and cognitive decline, dyskinesia and depression surprisingly resolve after a suicide attempt.